Rightslink® by Copyright Clearance Center

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

Author:

Philipp Gauckler,Jae Il Shin,Federico Alberici,Vincent Audard,Annette Bruchfeld,Martin Busch,Chee Kay Cheung,Matija Crnogorac,Elisa Delbarba,Kathrin Eller,Stanislas Faguer,Kresimir Galesic,Siân Griffin,Zdenka Hrušková,Anushya Jeyabalan et al.

Publication:

Autoimmunity Reviews

Publisher:

Elsevier

Date:

November 2020

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.